ATRIAL-NATRIURETIC-PEPTIDE AND URINARY DOPAMINE OUTPUT IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

被引:21
|
作者
CHAN, JCN
CRITCHLEY, JAJH
HO, CS
NICHOLLS, MG
COCKRAM, CS
SWAMINATHAN, R
机构
[1] CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT MED,SHA TIN,HONG KONG
[2] CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT CHEM PATHOL,SHA TIN,HONG KONG
关键词
ALBUMINURIA; ATRIAL NATRIURETIC PEPTIDE; CHINESE; HYPERTENSION; NON-INSULIN-DEPENDENT DIABETES; URINARY DOPAMINE OUTPUT;
D O I
10.1042/cs0830247
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Disturbances of sodium and water homoeostasis may contribute to the close association between diabetes, hypertension and proteinuria. We therefore studied the patterns of two natriuretic hormones, plasma atrial natriuretic peptide and urinary dopamine, in 165 Chinese patients with non-insulin-dependent diabetes mellitus controlled by diet or oral hypoglycaemic agents on two occasions over a 6-week period. Patients were divided into three groups based on the mean value of two 24 h urinary albumin excretion measurements. In group 1, 88 patients had normoalbuminuria (urinary albumin excretion less-than-or-equal-to 30 mg/day), in group 2, 48 patients had microalbuminuria (urinary albumin excretion between 30 and 300 mg/day), and in group 3, 29 patients had macroalbuminuria (urinary albumin excretion greater-than-or-equal-to 300 mg/day). 2. The supine systolic blood pressure (mean+/-SD) was higher in patients with abnormal albuminuria (group 1: 140.9+/-27.4 mmHg; group 2: 158.1+/-26.4 mmHg; group 3: 166.7+/-23.9 mmHg; F=13.1, P<0.001, analysis of variance). Urinary sodium output was similar in these three groups of patients. The geometric means (anti-logarithm of 95% confidence interval logarithm) of plasma atrial natriuretic peptide concentrations increased with increasing proteinuria [group 1: 33.3 (29.9-37.1) pg/ml; group 2: 39.1 (34.2-44.6) pg/ml; group 3: 50 (38.6-54.7) pg/ml; F=4.24, P<0.01; analysis of variance], whereas those of urinary dopamine output were related inversely to proteinuria [group 1: 1291.7 (1167.2-1437.0) nmol/day; group 2: 1142.3 (975.9-1337.2) nmol/day; group 3: 982.7 (775.7-1245) nmol/day; F=3.10, P<0.05, analysis of variance]. Using stepwise multiple regression analysis, plasma atrial natriuretic peptide concentration (r2=0.31, F=56.2, P<0.001) was associated with supine systolic blood pressure (beta=0.56, P<0.001), which was (r2=0.38, P<0.001) related to urinary albumin excretion (beta=0.23, P<0.001). In patients with urinary albumin excretion>30 mg/day, plasma atrial natriuretic peptide concentration was negatively correlated with urinary dopamine output (r=-0.25, P<0.02). 3. Based on these observations, we hypothesize that, in patients with non-insulin-dependent diabetes mellitus, defective dopamine mobilization in the renal tubules may cause impaired natriuresis with increased blood pressure. A compensatory rise in the plasma atrial natriuretic peptide concentration may then contribute to the development of abnormal albuminuria.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [31] ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH DIABETES-MELLITUS TYPE-I - EFFECTS ON SYSTEMIC AND RENAL HEMODYNAMICS AND RENAL EXCRETORY FUNCTION
    PREDEL, HG
    SCHULTEVELS, O
    SORGER, M
    GLANZER, K
    GELLER, C
    KRAMER, HJ
    AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (09) : 674 - 681
  • [32] Associations of hypertension and complications in non-insulin-dependent diabetes mellitus
    Mehler, PS
    Jeffers, BW
    Estacio, R
    Schrier, RW
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (02) : 152 - 161
  • [33] Pathogenesis of type II (non-insulin-dependent) diabetes mellitus
    Guillausseau, PJ
    Lubetzki, J
    ANNALES DE MEDECINE INTERNE, 1996, 147 (02): : 87 - 92
  • [34] URINARY ALBUMIN EXCRETION AS AN INDEX OF TOTAL CARDIOVASCULAR STRESS - RELATIONSHIP TO MACRO-ANGIOPATHIC COMPLICATIONS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    CAMPANINI, M
    AIROLDI, G
    MARINONE, M
    MONTEVERDE, A
    JOURNAL OF HYPERTENSION, 1993, 11 : S198 - S199
  • [35] LONG-TERM EFFICACY AND TOLERABILITY OF PRAVASTATIN IN HYPERCHOLESTEROLEMIA IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    KAZUMI, T
    YOSHINO, G
    ISHIDA, Y
    IWATANI, I
    MORITA, S
    TATEIWA, M
    KASUGA, M
    YOSHIDA, M
    KASAMA, T
    AMANO, M
    SAKAMOTO, T
    FUKUNAGA, H
    FUKUDA, T
    IMAMURA, Y
    INOUE, T
    DOI, K
    YAMASHIRO, Y
    NAKAMURA, Y
    HASHIMOTO, S
    OKA, T
    GOTO, T
    MORI, H
    MAEDA, M
    ORIBE, T
    HASEGAWA, M
    NISHIMOTO, S
    HASHIMOTO, T
    OHKI, A
    YAMADA, H
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 27 (01) : 61 - 68
  • [36] MANAGEMENT OF NEWLY DIAGNOSED NON-INSULIN-DEPENDENT (TYPE-2) DIABETES-MELLITUS - A RETROSPECTIVE AUDIT
    MARSIAJ, HI
    CATALANO, C
    SUM, CF
    HOME, PD
    ALBERTI, KGMM
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1991, 12 (02) : 129 - 136
  • [37] ALBUMIN EXCRETION RATE AND ITS RELATION TO KIDNEY-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    WIRTA, O
    PASTERNACK, A
    MUSTONEN, J
    OKSA, H
    KOIVULA, T
    HELIN, H
    JOURNAL OF INTERNAL MEDICINE, 1995, 237 (04) : 367 - 373
  • [38] SIMVASTATIN IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - EFFECT ON SERUM-LIPIDS, LIPOPROTEINS AND HEMOSTATIC MEASURES
    FARRER, M
    WINOCOUR, PH
    EVANS, K
    NEIL, HAW
    LAKER, MF
    KESTEVEN, P
    ALBERTI, KGMM
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 23 (02) : 111 - 119
  • [40] ATRIAL-NATRIURETIC-PEPTIDE IN NON-MODULATING ESSENTIAL-HYPERTENSION
    LUPARINI, RL
    FERRI, C
    SANTUCCI, A
    BALSANO, F
    HYPERTENSION, 1993, 21 (06) : 803 - 809